Table 4 |
||||
|
Spearman rank correlations between demographic and clinical factors and soy consumption (N = 100) |
||||
|
Predictors |
Soy consumption (yes versus no) |
Weekly gram weight of soy |
Weekly milligrams of Genistein |
Weekly milligrams of Daidzein |
|
|
||||
|
Age at Diagnosis |
0.014 |
0.06 |
0.12 |
0.12 |
|
|
||||
|
BMI |
-0.04 |
-0.11 |
-0.11 |
-0.11 |
|
|
||||
|
Ethnicity |
-0.23* |
0.18 |
0.13 |
0.13 |
|
|
||||
|
Stage at Diagnosis |
-0.18 |
-0.25* |
-0.25* |
-0.24* |
|
|
||||
|
Prior Treatment History |
-0.12 |
-0.19 |
-0.18 |
-0.18 |
|
|
||||
|
Menstrual Status |
0.07 |
0.11 |
0.14 |
0.14 |
|
|
||||
|
Estrogen/Progesterone Receptor Status |
0.16 |
0.08 |
0.07 |
0.07 |
|
|
||||
|
Tamoxifen Use |
-0.21* |
-0.20 |
-0.16 |
-0.16 |
|
|
||||
|
* p < 0.05 |
||||
|
Lammersfeld et al. Nutrition Journal 2009 8:2 doi:10.1186/1475-2891-8-2 |
||||